| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 12/15/2022 | 10.31% | Janney Montgomery Scott | → $40 | Downgrades | Buy → Neutral |
| 12/14/2022 | — | Janney Montgomery Scott | Downgrades | Buy → Neutral | |
| 12/13/2022 | — | Stephens & Co. | Downgrades | Overweight → Equal-Weight | |
| 12/13/2022 | — | Piper Sandler | Downgrades | Overweight → Neutral | |
| 10/25/2022 | 7.56% | JP Morgan | $41 → $39 | Maintains | Underweight |
| 10/19/2022 | 24.1% | Keefe, Bruyette & Woods | $48 → $45 | Downgrades | Outperform → Market Perform |
| 10/19/2022 | 15.83% | Truist Securities | $45 → $42 | Downgrades | Buy → Hold |
| 10/18/2022 | 15.83% | Truist Securities | $45 → $42 | Downgrades | Buy → Hold |
| 09/14/2022 | 24.1% | Truist Securities | $46 → $45 | Maintains | Buy |
| 09/13/2022 | — | Janney Montgomery Scott | Initiates Coverage On | → Buy | |
| 07/01/2022 | 7.56% | JP Morgan | $41 → $39 | Maintains | Underweight |
| 06/13/2022 | 35.14% | Truist Securities | $52 → $49 | Maintains | Buy |
| 01/19/2022 | 43.41% | Stephens & Co. | $51 → $52 | Maintains | Overweight |
| 07/08/2021 | 21.35% | DA Davidson | $47.5 → $44 | Upgrades | Neutral → Buy |
| 10/29/2020 | -17.26% | Keefe, Bruyette & Woods | → $30 | Downgrades | Outperform → Market Perform |
| 10/29/2020 | -11.75% | Piper Sandler | $27 → $32 | Upgrades | Neutral → Overweight |
| 10/28/2020 | -25.54% | JP Morgan | $28 → $27 | Downgrades | Neutral → Underweight |
| 05/01/2020 | -25.54% | SunTrust Robinson Humphrey | $24 → $27 | Maintains | Buy |
| 04/06/2020 | -48.98% | UBS | $41 → $18.5 | Maintains | Neutral |
| 01/22/2020 | 21.35% | Stephens & Co. | $42 → $44 | Maintains | Overweight |
| 01/02/2020 | 26.86% | SunTrust Robinson Humphrey | $43 → $46 | Maintains | Buy |
| 10/23/2019 | — | Raymond James | Downgrades | Outperform → Market Perform | |
| 10/10/2019 | 10.31% | DA Davidson | → $40 | Initiates Coverage On | → Neutral |
| 07/09/2019 | 15.83% | Stephens & Co. | → $42 | Upgrades | Equal-Weight → Overweight |
| 12/11/2018 | 18.59% | SunTrust Robinson Humphrey | → $43 | Initiates Coverage On | → Buy |
| 10/24/2018 | 18.59% | Raymond James | $47 → $43 | Maintains | Outperform |
| 10/24/2018 | 10.31% | Stephens & Co. | $47 → $40 | Downgrades | Overweight → Equal-Weight |
| 03/22/2018 | 21.35% | UBS | → $44 | Initiates Coverage On | → Neutral |
What is the target price for FB Financial (FBK)?
The latest price target for FB Financial (NYSE: FBK) was reported by Janney Montgomery Scott on December 14, 2022. The analyst firm set a price target for $0.00 expecting FBK to fall to within 12 months (a possible -100.00% downside). 12 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for FB Financial (FBK)?
The latest analyst rating for FB Financial (NYSE: FBK) was provided by Janney Montgomery Scott, and FB Financial downgraded their neutral rating.
When is the next analyst rating going to be posted or updated for FB Financial (FBK)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of FB Financial, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for FB Financial was filed on December 14, 2022 so you should expect the next rating to be made available sometime around December 14, 2023.
Is the Analyst Rating FB Financial (FBK) correct?
While ratings are subjective and will change, the latest FB Financial (FBK) rating was a downgraded with a price target of $0.00 to $0.00. The current price FB Financial (FBK) is trading at is $36.26, which is out of the analyst's predicted range.